Neuroendocrinology · 2008
Effects of sex steroids on the neurotransmitter-specific aromatic amino acids phenylalanine, tyrosine, and tryptophan in transsexual subjects.
Клиническое исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Giltay Erik J, Bunck Mathijs C, Gooren Louis J, Zitman Frans G, Diamant Michaela, Teerlink Tom
Аннотация
BACKGROUND/AIMS: Phenylalanine, tyrosine and tryptophan are essential aromatic amino acids and precursors of dopamine, norepinephrine, epinephrine and serotonin. The aim of this study was to assess whether sex steroids affect plasma levels of these aromatic amino acids.
METHODS: 15 male-to-female (M-F) transsexuals were treated with 100 microg/day ethinyl estradiol and 100 mg/day cyproterone acetate, and 14 female-to-male (F-M) transsexuals were treated with testosterone esters 250 mg i.m. per 2 weeks. Plasma levels of hormones and amino acids were measured at baseline and after 4 and 12 months of cross-sex hormone administration, and analyzed by general linear models for repeated measures.
RESULTS: Plasma phenylalanine decreased by 7.5% (SD 3.0; p = 0.01); tyrosine by 18.3% (SD 4.6; p < 0.001), and tryptophan by 7.8% (SD 4.7; p = 0.03) after 12 months of estrogen + anti-androgen administration to M-F transsexuals. Administration of testosterone in F-M transsexuals did not induce significant changes in plasma levels of phenylalanine and tyrosine, but increased plasma tryptophan by 18.2% (SD 20.6; p = 0.001).
CONCLUSION: Estrogens and anti-androgens reduce circulating levels of phenylalanine, tyrosine, and tryptophan in men, whereas testosterone administration increases plasma tryptophan levels in women. Sex steroids may influence the availability of neurotransmitter precursors.
METHODS: 15 male-to-female (M-F) transsexuals were treated with 100 microg/day ethinyl estradiol and 100 mg/day cyproterone acetate, and 14 female-to-male (F-M) transsexuals were treated with testosterone esters 250 mg i.m. per 2 weeks. Plasma levels of hormones and amino acids were measured at baseline and after 4 and 12 months of cross-sex hormone administration, and analyzed by general linear models for repeated measures.
RESULTS: Plasma phenylalanine decreased by 7.5% (SD 3.0; p = 0.01); tyrosine by 18.3% (SD 4.6; p < 0.001), and tryptophan by 7.8% (SD 4.7; p = 0.03) after 12 months of estrogen + anti-androgen administration to M-F transsexuals. Administration of testosterone in F-M transsexuals did not induce significant changes in plasma levels of phenylalanine and tyrosine, but increased plasma tryptophan by 18.2% (SD 20.6; p = 0.001).
CONCLUSION: Estrogens and anti-androgens reduce circulating levels of phenylalanine, tyrosine, and tryptophan in men, whereas testosterone administration increases plasma tryptophan levels in women. Sex steroids may influence the availability of neurotransmitter precursors.